PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
2026-06-01T    Health Care/Hospital   Medical/Pharmaceuticals 
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
2026-06-01T    Health Care/Hospital   Medical/Pharmaceuticals 
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
2026-05-31T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
2026-05-31T    Health Care/Hospital   Medical/Pharmaceuticals 
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
2026-05-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved